A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Condition(s):Glioma; Malignant Glioma; Astrocytoma, Grade II; Oligodendroglioma; Glioma, Astrocytic; Oligoastrocytoma, MixedLast Updated:March 27, 2023Active, not recruiting